The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Ctexli (chenodiol) to treat adults with ...

The National Institute of Health and Care Excellence (NICE) has recommended pharmaand’s (pharma&) Rubraca (rucaparib) as a ...

Recce Pharmaceuticals has shared positive data from a mid-stage study of its RECCE 327 topical gel (R327G) in acute bacterial ...

Global healthcare communications company Porterhouse Medical has announced the appointment of Michael Tague as president of ...

In 1958, in his book Nation of Immigrants, John F Kennedy mused: ‘One of America’s characteristics has always been the lack ...

Coming in first on the list of Top 25 Pharma Companies US Rx is AbbVie, reaching $41,857m in US Rx revenue in 2023 and ...

Gilead Sciences’ seladelpar has been granted conditional marketing authorisation by the European Commission (EC) to treat ...

A 2024 ICON survey of over 100 oncology developers’ pipelines reflected a diverse and highly complex landscape of emerging ...

ISPM (UK) Ltd ISPM has been involved in leading the changes to bring about significant business improvement across a wide section of industry including chemicals, engineering, pharmaceuticals, ...

Cotswolds Water Park can accommodate from 2 to 800 people for business meetings, conferences, events, team building and outdoor activities in the Cotswolds. We understand that there is no such thing ...

An independent company with six distinctive hotels, we pride ourselves on delivering highly personal service and attention to detail. At the same time, our professional events organisers will be ...

The European Commission (EC) has approved Biocon Biologics’ Yesintek, an ustekinumab biosimilar referencing Johnson & Johnson’s Stelara, to treat multiple inflammatory diseases.